Your browser doesn't support javascript.
Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection.
To, Kelvin Kai-Wang; Hung, Ivan Fan-Ngai; Chan, Kwok-Hung; Yuan, Shuofeng; To, Wing-Kin; Tsang, Dominic Ngai-Chong; Cheng, Vincent Chi-Chung; Chen, Zhiwei; Kok, Kin-Hang; Yuen, Kwok-Yung.
  • To KK; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Hung IF; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Chan KH; Department of Medicine, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Yuan S; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • To WK; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Tsang DN; Department of Pathology, Princess Margaret Hospital, Hong Kong Special Administrative Region, China.
  • Cheng VC; Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
  • Chen Z; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Kok KH; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Yuen KY; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
Clin Infect Dis ; 72(10): e659-e662, 2021 05 18.
Article in English | MEDLINE | ID: covidwho-1232198
ABSTRACT
We recently reported a patient with coronavirus disease 2019 reinfection. Here, we show that serum neutralizing antibodies could be detected during the first episode but not at the presentation of the second episode. During reinfection, neutralizing antibodies and high avidity immunoglobulin G were found within 8 days after hospitalization, whereas immunoglobulin M response was absent.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid